Boulder, Colorado-based M2 Orthopedics (M2O) has secured $65 million in funding, led by Archimedes Health Investors, a private equity firm focused on the healthcare industry, and participated in by Heritage Medical Systems and The Firmament Group.
Practice Management Firm Raises $65M to Purchase Clinics
1 min read Premium comments
Secondary#m2orthopedics
M2O is a practice management company that serves orthopedic practices and surgeons. The recent funding will be used to acquire Anderson Orthopaedic Clinic, based in Arlington, Virginia, as well as orthopedic surgery center Harborside Surgery Center, based in Oxon Hill, Maryland.
OTW spoke with M2O Co-Founder and CEO Marshall Maran about the new funds. Maran told OTW, “This funding enables us to propel M2O’s presence in Northern Virginia, including supporting the first acquisition of Anderson Orthopaedic Clinic.”
Maran continued, “By building our team with the appointments of noted experts in the industry, we’re able to scale our ground-breaking approach for modern practice management that helps the country’s top surgeons maintain their independence and scale themselves.”
C. Anderson Engh, Jr., M.D. of the Anderson Orthopaedic Clinic explained, “Our primary objective has been to provide high quality care to our patients. In addition, our practice has been deeply involved in training young surgeons through our fellowship program and in clinical research, all of which further the development and knowledge of the field of orthopedics.”
Dr. Engh continued, “Through our partnership with M2O, we are able to continue our focus on these three critical aspects of our practice, while having the resources and capabilities to develop and grow, which are critical in today’s environment.”
Maran also discussed the company’s plans for expansion in the upcoming year. Maran informed OTW, “We are in a high-growth mode and are always looking for ways to expand our presence and our capabilities. We anticipate additional acquisitions of clinics in the Washington, D.C. region, as well as other targeted geographies.”
Maran continued, “Our goal is to continue to partner with top surgeons to support them and their practices in more impactful ways, so that they can focus on treating patients and delivering great care.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.